Tolterodine in the Treatment of Male LUTS

EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction

(2013) Matthias Oelke et al.   EUROPEAN UROLOGY

Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience

(2012) Adrian Wagg et al.   BJU INTERNATIONAL

Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline

(2012) E. Ann Gormley et al.   JOURNAL OF UROLOGY

The Role of Antimuscarinics in the Management of Men With Symptoms of Overactive Bladder Associated With Concomitant Bladder Outlet Obstruction: An Update

(2011) Anastasios Athanasopoulos et al.   EUROPEAN UROLOGY

Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia

(2011) Kevin T. McVary et al.   JOURNAL OF UROLOGY

Efficacy and safety of tolterodine extended-release in men with overactive bladder symptoms treated with an α-blocker: effect of baseline prostate-specific antigen concentration

(2010) Christopher R. Chapple et al.   BJU INTERNATIONAL

Efficacy and Safety of Tolterodine Extended Release and Dutasteride in Male Overactive Bladder Patients With Prostates >30 Grams

(2010) Doreen E. Chung et al.   UROLOGY

Tolterodine extended-release for overactive bladder

(2009) Doreen E Chung et al.   EXPERT OPINION ON PHARMACOTHERAPY

Established Medical Therapy for Benign Prostatic Hyperplasia

(2009) Gregory B. Auffenberg et al.   UROLOGIC CLINICS OF NORTH AMERICA

Age and Bladder Outlet Obstruction Are Independently Associated with Detrusor Overactivity in Patients with Benign Prostatic Hyperplasia

(2008) Matthias Oelke et al.   EUROPEAN UROLOGY

A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive Bladder

(2008) Giacomo Novara et al.   EUROPEAN UROLOGY

Tolterodine Treatment Improves Storage Symptoms Suggestive of Overactive Bladder in Men Treated With α-Blockers

(2008) Christopher Chapple et al.   EUROPEAN UROLOGY